Tripterygium wilfordii whole

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Tripterygium wilfordii whole
Accession Number
DB14277
Type
Biotech
Groups
Experimental
Description

Tripterygium wilfordii whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Synonyms
  • Thunder God Vine Whole
  • Tripterygium
  • Tripterygium Whole
  • Tripterygium Wilfordii
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
PAMO Kill NaturalLiquid28 g/100mLTopicalGeoRim Pharmaceutical2013-10-07Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
PAMO Kill NaturalTripterygium wilfordii whole (28 g/100mL)LiquidTopicalGeoRim Pharmaceutical2013-10-07Not applicableUs
Categories
Not Available
UNII
GBE347P41D
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2RecruitingTreatmentRheumatoid Arthritis1
2, 3Unknown StatusTreatmentEarly Ankylosing Spondylitis1
Not AvailableCompletedTreatmentActive Rheumatoid Arthritis / Rheumatoid Arthritis1
Not AvailableCompletedTreatmentGlomerulosclerosis, Focal Segmental / Proteinuria1
Not AvailableCompletedTreatmentIdiopathic Membranous Nephropathy1
Not AvailableCompletedTreatmentNephritis, Lupus1
Not AvailableCompletedTreatmentRheumatoid Arthritis1
Not AvailableTerminatedTreatmentIgA Nephropathy1
Not AvailableTerminatedTreatmentKidney, Polycystic1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
LiquidTopical28 g/100mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on July 05, 2018 11:13 / Updated on May 01, 2019 11:59